Summary
In recent years, large discrepancies were described in the success rate of the tyrosinase reverse transcription polymerase chain reaction (RT-PCR) for detecting melanoma cells in the peripheral blood of melanoma patients. We present a quality control study in which we analysed the reproducibility of detection of tyrosinase and MART-1 transcripts in 106 blood samples from 68 melanoma patients (mainly stages III and IV). With this study, we aimed to improve insight in the reproducibility of a RT-PCR for the detection of (minimal) amounts of circulating melanoma cells. We performed two reverse transcriptions on each mRNA sample and performed tyrosinase and MART-1 nested PCRs in duplicate per cDNA sample. Thus, four tyrosinase and four MART-1 measurements were performed per blood sample. In our study, the majority of blood samples was negative for tyrosinase (80%) or MART-1 (66%). Only four samples were positive in all four determinations for tyrosinase and seven for MART-1. Variable results (1–3 times positive results) were obtained for tyrosinase and MART-1 in 16% and 27% respectively. MART-1 PCR had a better performance than tyrosinase PCR. Sensitivity increased when both markers were used. We reasoned that the low number of melanoma marker PCR-positive blood samples can be explained by differences in mRNA quality. By using real-time quantitative PCR, we found that this was not the case: amplification of porphobilinogen deaminase (PBGD), a low copy household gene, was not different in blood samples in which a melanoma marker was not detected from groups in which this marker was detected more or less consistently (1–4 times). When applying real-time quantitative PCR for tyrosinase and MART-1, we found that a low amount of SK-MEL-28 cell equivalents was present in the blood of melanoma patients, with a higher number of equivalents in the group with a consistently positive result. We conclude that low reproducibility of a repeated assay for the detection of circulating melanoma cells is not caused by differences in mRNA quality between the samples, but due to low numbers of amplifiable target mRNA molecules in the mRNA sample. Use of more than one marker and repetition of the assay will increase the probability of finding positive PCR results.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Battayani, Z., Grob, J. J., Xerri, L., Noe, C., Zarour, H., Houvaeneghel, G., Delpero, J. R., Birmbaum, D., Hassoun, J. & Bonerandi, J. J. (1995). Polymerase chain reaction detection of circulating melanocytes as a prognostic marker in patients with melanoma. Arch Dermatol 131: 443–447.
Brandt, B., Junker, R., Griwatz, C., Heidl, S., Brinkmann, O., Semjonow, A., Assmann, G. & Zanker, K. S. (1996). Isolation of prostate-derived single cell clusters from human peripheral blood. Cancer Res 56: 4556–4561.
Brossart, P., Keilholz, U., Willhauck, M., Scheibenbogen, C., Mohler, T. & Hunstein, W. (1993). Hematogenous spread of malignant melanoma cells in different stages of disease. J Invest Dermatol 101: 887–889.
Brossart, P., Keilholz, U., Scheibenbogen, C., Mohler, T., Willhauck, M. & Hunstein, W. (1994). Detection of residual tumor cells in patients with malignant melanoma responding to immunotherapy. J Immunother 15: 38–41.
Brossart, P., Schmier, J-W, Kruger, S., Willhauck, M., Scheibenbogen, C., Mohler, T. & Keilholz, U. (1995). A polymerase chain reaction-based semiquantitative assessment of malignant melanoma cells in peripheral blood. Cancer Res 55: 4065–4068.
Burchill, S. A., Bradbury, F. M., Smith, B., Lewis, I. J. & Selby, P. (1994). Neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction (RT-PCR) for tyrosine hydroxylase mRNA. Int J Cancer 57: 671–675.
Buzaid, A. C. & Balch, C. M. (1996). Polymerase chain reaction for detection of melanoma in peripheral blood: too early to assess clinical value. J Natl Cancer Inst 88: 569–570.
Chomczynski, P. & Sacchi, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156–159.
De Vries, T. J., Fourkour, A., Wobbes, T., Verkroost, G., Ruiter, D. J. & Van Muijen, G. N. P. (1997). Heterogeneous expression of immunotherapy candidate proteins gp100, MART-1 and tyrosinase in human melanoma cell lines and in human melanocytic lesions. Cancer Res 57: 3223–3229.
Farthmann, B., Eberle, J., Krasagatis, K., Gstottner, M., Wang, N., Bisson, S. & Orfanos, C. E. (1998). RT-PCR for tyrosinase-mRNA-positive cells in peripheral blood: evaluation strategy and correlation with known prognostic markers in 123 melanoma patients. J Invest Dermatol 110: 263–268.
Foss, A. J. E., Guille, M. J., Occleston, N. L., Hykin, P. G., Hungerford, J. L. & Lightman, S. (1995). The detection of melanoma cells in peripheral blood by reverse transcription-polymerase chain reaction. Br J Cancer 72: 155–159.
Ghossein, R. A., Coit, D., Brennan, M., Zhang, Z. F., Wang, Y., Bhattacharya, S., Houghton, A. & Rosai, J. (1998). Prognostic significance of peripheral blood and bone marrow tyrosinase messenger RNA in malignant melanoma. Clin Cancer Res 4: 419–428.
Gibson, U. E. M., Heid, C. A. & Williams, P. M. (1996). A novel method for real time quantitative RT-PCR. Genome Res 6: 995–1001.
Glaser, R., Rass, K., Seiter, S., Hauschild, A., Christophers, E. & Tilgen, W. (1997). Detection of circulating melanoma cells by specific amplification of tyrosinase complementary DNA is not a reliable tumor marker in melanoma patients: a clinical two-center study. J Clin Oncol 15: 2818–2825.
Heid, C. A., Stevens, J., Livak, K. J. & Williams, P. M. (1996). Real time quantitative PCR. Genome Res 6: 986–994.
Higuchi, R., Fockler, C., Dollinger, G. & Watson, R. (1993). Kinetic PCR analysis: real-time monitoring of DNA amplification reactions. Biotechnology 11: 1026–1030.
Holland, P. M., Abramson, R. D., Watson, R. & Gelfand, D. H. (1991). Detection of specific polymerase chain reaction product by utilizing the 5′—3′ exonuclease activity of Thermus aquaticus DNA polymerase. Proc Natl Acad Sci USA 88: 7276–7280.
Hoon, D. S., Yuzuki, D., Hayashida, M. & Morton, D. L. (1995). Melanoma patients immunized with melanoma cell vaccine induce antibody responses to recombinant MAGE-1 antigen. J Immunol 154: 730–737.
Johnson, P. W. M., Burchill, S. A. & Selby, P. J. (1995). The molecular detection of circulating tumour cells. Br J Cancer 72: 268–276.
Jung, F. A., Buzaid, A. C., Ross, M. I., Woods, K. V., Lee, J. J., Albitar, M. & Grimm, E. A. (1997). Evaluation of tyrosinase mRNA as a tumor marker in the blood of melanoma patients. J Clin Oncol 15: 2826–2831.
Jung, R., Ahmed-Nejad, P., Wimmer, M., Gerhard, M., Wagener, C. & Neumaier, M. (1997). Quality management and influential factors for the detection of single metastatic cancer cells by reverse transcriptase polymerase chain reaction. Eur J Chem Clin Biochem 35: 3–10.
Keilholz, U., Willhauck, M., Scheibenbogen, C., De Vries, T. J. & Burchill, S. (1997). Polymerase chain reaction detection of circulating tumour cells. Melanoma Res 7: S133–S141.
Keilholz, U., Willhauck, M., Rimoldi, D., Brasseur, F., Dummer, W., Rass, K., De Vries, T., Blaheta, J., Voit, C., Lethe, B. & Burchill, S. (1998). Reliability of RT-PCR-based assays for detection of circulating tumour cells: a quality-assurance initiative of the EORTC melanoma cooperative group. Eur J Cancer 34: 750–753.
Kunter, U., Buer, J., Probst, M., Duensing, S., Dallmann, I., Grosse, J., Kirchner, H., Schluepen, E. M., Volkenandt, M., Ganser, A. & Atzpodien, J. (1996). Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma. J Natl Cancer Inst 88: 590–594.
Livak, K. J., Flood, S. J., Marmaro, J., Giusti, W. & Deetz, K. (1995). Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization. PCR Methods Appl 4: 357–362.
Mellado, B., Colomer, D., Castel, T., Munoz, M., Carballo, E., Galan, M., Mascaro, J. M., Vives-Corrons, J. L., Grau, J. J. & Estape, J. (1996). Detection of circulating neoplastic cells by reverse-transcriptase polymerase chain reaction in malignant melanoma: association with clinical stage and prognosis. J Clin Oncol 14: 2091–2097.
Mori, M., Mimori, K., Inoue, H., Barnard, G. F., Tsuji, K., Nanbara, S., Ueo, H. & Akiyoshi, T. (1995). Detection of cancer micrometastases in lymph nodes by reverse transcription-polymerase chain reaction. Cancer Res 55: 3417–3420.
Pittman, K., Burchill, S., Smith, B., Southgate, J., Joffe, J., Gore, M. & Selby, P. (1996). Reverse transcriptase-polymerase chain reaction for expression of tyrosinase to identify malignant melanoma cells in peripheral blood. Ann Oncol 7: 297–301.
Reinhold, U., Ludtke-Handjery, H-C, Schnautz, S., Kreysel, H-W & Abken, H. (1997). The analysis of tyrosinase-specific mRNA in blood samples of melanoma patients by RT-PCR is not a useful test for metastatic tumor progression. J Invest Dermatol 108: 166–169.
Schoenfeld, A., Luqmani, Y., Smith, D., O’Reilley, S., Shousha, S., Sinnet, H. D. & Coombes, R. C. (1994). Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction. Cancer Res 54: 2986–2990.
Smith, B., Selby, P., Southgate, J., Pittman, K., Bradley, C. & Blair, G. E. (1991). Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 338: 1227–1229.
Stevens, G. L., Scheer, W. D. & Levine, E. A. (1996). Detection of tyrosinase mRNA from the blood of melanoma patients. Cancer Epidemiology, Biomarkers and Prevention 5: 293–296.
Van der Velde-Zimmerman, D., Roijers, J. F. M., Bouwens-Rombouts, A., De Weger, R. A., De Graaf, P. W., Tilanus, M. G. J. & Van den Tweel, J. G. (1996). Molecular test for the detection of tumor cells in blood and sentinel nodes of melanoma patients. Am J Pathol 149: 759–764.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
de Vries, T., Fourkour, A., Punt, C. et al. Reproducibility of detection of tyrosinase and MART-1 transcripts in the peripheral blood of melanoma patients: a quality control study using real-time quantitative RT-PCR. Br J Cancer 80, 883–891 (1999). https://doi.org/10.1038/sj.bjc.6690436
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690436
Keywords
This article is cited by
-
Clonidine increases bone resorption in humans
Osteoporosis International (2016)
-
Development of TaqMan® MGB fluorescent real-time PCR assay for the detection of anatid herpesvirus 1
Virology Journal (2009)
-
Effect of thrombin peptide 508 (TP508) on bone healing during distraction osteogenesis in rabbit tibia
Cell and Tissue Research (2007)
-
Melanoma-inhibiting activity (MIA) mRNA is not exclusively transcribed in melanoma cells: low levels of MIA mRNA are present in various cell types and in peripheral blood
British Journal of Cancer (1999)